Confused between IELTS, TOEFL and PTE? Compare their format, difficulty level, timing, and acceptance to decide which English ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...

Quantinuum has unveiled a third-generation quantum computer that could be easier to scale up than rival approaches. The US- and UK-based company Quantinuum today unveiled Helios, its third-generation ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...

India conducted an unprecedented night test launch of the Agni-Prime medium-range ballistic missile (MRBM) from a rail-based mobile launcher on September 24, according to an Indian Ministry of Defense ...

Maybe your interest in longevity is entrepreneurial, since one of the largest addressable markets is people who want to live longer, healthier lives. (I’ve never heard anyone say, “Yeah, I hope I ...

London-based Quantum Motion Technologies Ltd. announced today it has delivered the industry’s first quantum computer built using traditional semiconductor chipmaking processes, the same technology ...

The federal government program that mailed free at-home COVID-19 tests to households is no longer active. Some insurance providers may still cover the cost of at-home tests, and free tests may be ...

A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine. Led by a team from ...

Earlier this month, President Trump signed a memorandum requiring increased transparency in higher education admissions. The purpose of the order is to ensure that universities are admitting students ...

Please provide your email address to receive an email when new articles are posted on . Only 49% of those with an abnormal blood-based screening test had a colonoscopy within 6 months. Follow-up was ...